fagaronine has been researched along with Adenocarcinoma, Basal Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barthomeuf, C; Debiton, E; Duval, O; Forfar, I; Hélesbeux, JJ; Jarry, C; Richomme, P; Vanquelef, E | 1 |
Bisagni, E; Croisy, A; Janin, YL; Riou, JF | 1 |
2 other study(ies) available for fagaronine and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Synthesis and PC3 androgen-independent prostate cells antiproliferative effect of fagaronine derivatives.
Topics: Adenocarcinoma; Alkaloids; Androgens; Antineoplastic Agents; Benzophenanthridines; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Male; Molecular Structure; Phenanthridines; Prostatic Neoplasms | 2007 |
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |